These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2575348)

  • 1. Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
    Carrera CJ; Yamanaka H; Piro LD; Lotz M; Carson DA
    Adv Exp Med Biol; 1989; 253B():219-25. PubMed ID: 2575348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
    Carrera CJ; Terai C; Lotz M; Curd JG; Piro LD; Beutler E; Carson DA
    J Clin Invest; 1990 Nov; 86(5):1480-8. PubMed ID: 1700795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
    Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
    J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
    Carson DA; Wasson DB; Esparza LM; Carrera CJ; Kipps TJ; Cottam HB
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2970-4. PubMed ID: 1348362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
    Santana VM; Mirro J; Harwood FC; Cherrie J; Schell M; Kalwinsky D; Blakley RL
    J Clin Oncol; 1991 Mar; 9(3):416-22. PubMed ID: 1671875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
    Juliusson G; Liliemark J
    Blood; 1992 Feb; 79(4):888-94. PubMed ID: 1346578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
    Saven A; Carrera CJ; Carson DA; Beutler E; Piro LD
    Blood; 1992 Aug; 80(3):587-92. PubMed ID: 1353380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of pentostatin and cladribine in hairy cell leukemia.
    Johnston JB
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed cell death and adenine deoxynucleotide metabolism in human lymphocytes.
    Carson DA; Carrera CJ; Wasson DB; Yamanaka H
    Adv Enzyme Regul; 1988; 27():395-404. PubMed ID: 2907967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of 2-chloro-2'-deoxyadenosine in human plasma.
    Liliemark J; Pettersson B; Juliusson G
    Biomed Chromatogr; 1991 Nov; 5(6):262-4. PubMed ID: 1684727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.
    Carson DA; Wasson DB; Taetle R; Yu A
    Blood; 1983 Oct; 62(4):737-43. PubMed ID: 6136305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
    Cheson BD
    Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
    Estey EH; Kurzrock R; Kantarjian HM; O'Brien SM; McCredie KB; Beran M; Koller C; Keating MJ; Hirsch-Ginsberg C; Huh YO
    Blood; 1992 Feb; 79(4):882-7. PubMed ID: 1346577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
    Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD
    J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma.
    Betticher DC; Zucca E; von Rohr A; Egger T; Radford JA; Ambrosetti A; Bürki K; Rufener B; Schmitz SF; Cerny T
    Ann Oncol; 1996 Oct; 7(8):793-9. PubMed ID: 8922192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
    Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
    Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    Seto S; Carrera CJ; Wasson DB; Carson DA
    J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.